Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.

Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 is displayed instead of v3.4.1, indicating a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page footer now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a glossary display option and new page metadata labels ('Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and updated the site revision to v3.4.0. Removed the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the previous revision note v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedA new revision tag v3.3.4 was added and the previous v3.3.3 tag removed; this represents a minor update not affecting the displayed study information.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded New Jersey and New York locations and updated the last update posted to Estimated 2025-12-18 with revision v3.3.3. The previous 'Active, not recruiting' designation and older location lists were removed.SummaryDifference0.8%

- Check84 days agoChange DetectedA new publication citation for Chen et al., J Thorac Oncol 2025 was added to the Publications section and the previous version of the citation was removed.SummaryDifference0.1%

Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.